SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $261,291 | -21.7% | 75,300 | +4.9% | 0.00% | – |
Q2 2023 | $333,917 | +40.6% | 71,810 | +39.7% | 0.00% | – |
Q1 2023 | $237,468 | -42.8% | 51,400 | 0.0% | 0.00% | – |
Q4 2022 | $415,312 | +55.5% | 51,400 | +6.9% | 0.00% | – |
Q3 2022 | $267,000 | +58.9% | 48,100 | +48.9% | 0.00% | – |
Q2 2022 | $168,000 | -90.1% | 32,300 | -84.3% | 0.00% | -100.0% |
Q1 2022 | $1,693,000 | -47.2% | 205,924 | -4.5% | 0.00% | 0.0% |
Q4 2021 | $3,208,000 | -17.0% | 215,566 | +5.3% | 0.00% | -50.0% |
Q3 2021 | $3,866,000 | +88.4% | 204,677 | +85.5% | 0.00% | +100.0% |
Q2 2021 | $2,052,000 | +1.5% | 110,357 | +24.2% | 0.00% | 0.0% |
Q1 2021 | $2,022,000 | +486.1% | 88,824 | +458.6% | 0.00% | – |
Q4 2020 | $345,000 | +167.4% | 15,900 | +24.2% | 0.00% | – |
Q3 2020 | $129,000 | +30.3% | 12,800 | 0.0% | 0.00% | – |
Q2 2020 | $99,000 | – | 12,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
BVF INC/IL | 826,825 | $15,371,000 | 0.58% |